Acute coronary syndromes

only PCI. Full details of the evidence and the committee's discussion are in evidence review E: culprit versus complete revascularisation. Drug-eluting stents in primary PCI 1.1.18 If stenting is indicated, offer a drug-eluting stent to people with acute STEMI undergoing revascularisation by primary PCI. [2020] For a short explanation of why the committee made the 2020 recommendation and how it might affect practice, see the rationale and impact section on drug-eluting stents in primary PCI. Full details of the evidence and the committee's discussion are in evidence review F: drug-eluting stents. Fibrinolysis 1.1.19 Offer fibrinolysis to people with acute STEMI presenting within 12 hours of onset of symptoms if primary PCI cannot be delivered within 120 minutes of the time when fibrinolysis could have been given. [2013] For recommendations in NICE technology appraisal guidance on choosing thrombolytic treatments for acute STEMI, see guidance on the use of drugs for early thrombolysis (TA52, 2002). 1.1.20 When treating people with fibrinolysis, give an antithrombin at the same time. [2013] 1.1.21 Offer an electrocardiogram (ECG) to people with acute STEMI treated with fibrinolysis, 60 to 90 minutes after administration. For those who have residual Acute coronary syndromes (NG185) ST-segment elevation suggesting failed coronary
